Community-Based Care Aids Disparities in Chronic Disease Prevention

Chronic kidney disease (CKD) has negatively impacted the health of racial and ethnic minority patients, but research from a Mount Sinai study showed that community-based care could be essential to improve disparities in chronic disease prevention and management.

Previous research uncovered that risk variants in the apolipoprotein L1 (APOL1) gene were common in individuals of West African ancestry, resulting in a higher risk for CKD among Black patients.

“African Americans have a higher risk of kidney disease development and progression. While race is a social construct, and this disparity is multifactorial and structural, ancestry has genetic components,” Girish N. Nadkarni, MD, MPH, the Irene, and Arthur M Fishberg Professor of Medicine at Icahn Mount Sinai and the lead author of the study said in a public statement.

A study showed how a community-based healthcare program helped with chronic disease prevention and management for Black patients, addressing racial disparities in chronic disease outcomes.